Small steps of improvement in small-cell lung cancer (SCLC) within two decades: A comprehensive analysis of 484 patients

Lung Cancer

Volumn 84, Issue 2, 2014, Pages 168-174

  Fiegl, M ^a   Pircher, A ^a   Waldthaler, C ^a   Gamerith, G ^a   Kocher, F ^a   Pall, G ^a   Nevinny, M ^a   Schmid, T ^a   Sterlacci, W ^b   Jamnig, H ^c   Zangerl, G ^d   Zabernigg, A ^d   Oberaigner, W ^e   Hilbe, W ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c Academic Natters Hospital   (Austria)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

^e Department of Pneumology Academic Natters Hospital ^*  (Austria)

Author keywords

Chemotherapy; Comorbidity; Radiochemotherapy; SCLC; Surgery; Symptoms

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IRINOTECAN; LACTATE DEHYDROGENASE; PLATINUM; TOPOTECAN; VINCRISTINE;

ADVANCED CANCER; AGED; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER ADJUVANT THERAPY; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER STAGING; CHEMORADIOTHERAPY; COMORBIDITY; COUGHING; DYSPNEA; EARLY CANCER; FEMALE; FEVER; GROUPS BY AGE; HEMOPTYSIS; HOARSENESS; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEUROLOGIC DISEASE; NIGHT SWEAT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENCE FREE SURVIVAL; TREATMENT RESPONSE; UNIVERSITY HOSPITAL; WEIGHT REDUCTION; ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; DISEASE FREE SURVIVAL; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PALLIATIVE THERAPY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SMALL CELL LUNG CARCINOMA; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY, ADJUVANT; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PALLIATIVE CARE; PROPORTIONAL HAZARDS MODELS; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES; SMALL CELL LUNG CARCINOMA; TREATMENT OUTCOME;

EID: 84899473313     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.02.005     Document Type: Article

References (31)

1. Govindan R., Page N., Morgensztern D., Read W., Tierney R., Vlahiotis A., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006, 24:4539-4544.
2. Baldotto C.S., Cronemberger E.H., de Biasi P., Zamboni M., Sousa A., Zukin M., et al. Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy. Support Care Cancer 2012, 20:2721-2727.
3. Agra Y., Pelayo M., Sacristan M., Sacristan A., Serra C., Bonfill X. Chemotherapy versus best supportive care for extensive small cell lung cancer. Cochrane Database Syst Rev 2003, CD001990.
4. Oze I., Hotta K., Kiura K., Ochi N., Takigawa N., Fujiwara Y., et al. Twenty-seven years of phase III trials for patients with extensive disease small-cell lung cancer: disappointing results. PLoS One 2009, 4:e7835.
5. Pircher A., Ulsperger E., Hack R., Jamnig H., Pall G., Zelger B., et al. Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer. Anticancer Res 2011, 31:2949-2955.
6. Fiegl M., Erdel M., Tinhofer I., Brychtova Y., Panovska A., Doubek M., et al. Clinical outcome of pretreated B-cell chronic lymphocytic leukemia following alemtuzumab therapy: a retrospective study on various cytogenetic risk categories. Ann Oncol 2010, 21:2410-2419.
7. Kim Y.H., Goto K., Yoh K., Niho S., Ohmatsu H., Kubota K., et al. Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy. Cancer 2008, 113:2518-2523.
8. Hermes A., Waschki B., Gatzemeier U., Reck M. Characteristics, treatment patterns and outcomes of patients with small cell lung cancer-a retrospective single institution analysis. Lung Cancer 2011, 71:363-366.
9. Ou S.H., Ziogas A., Zell J.A. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity. J Thorac Oncol 2009, 4:37-43.
10. van Oosterhout A.G., van de P.M., ten Velde G.P., Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 1996, 77:1434-1441.
11. Hong S., Cho B.C., Choi H.J., Jung M., Lee S.H., Park K.S., et al. Prognostic factors in small cell lung cancer: a new prognostic index in Korean patients. Oncology 2010, 79:293-300.
12. Hansen O., Sorensen P., Hansen K.H. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period. Lung Cancer 2010, 68:111-114.
13. Nagy-Mignotte H., Guillem P., Vignoud L., Coudurier M., Vesin A., Bonneterre V., et al. Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients. Lung Cancer 2012, 78:112-120.
14. Sterlacci W., Stockinger R., Schmid T., Bodner J., Hilbe W., Waldthaler C., et al. The elderly patient with surgically resected non-small cell lung cancer-a distinct situation. Exp Gerontol 2012, 47:237-242.
15. Sterlacci W., Tzankov A., Veits L., Oberaigner W., Schmid T., Hilbe W., et al. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics. Am J Clin Pathol 2011, 135:611-618.
16. Stahel R., Ginsberg R., Havemann K. Staging and prognostic factors in small cell lung cancer: a consensus report. Lung Cancer 1989, 5:119-126.
17. Nicholson S.A., Beasley M.B., Brambilla E., Hasleton P.S., Colby T.V., Sheppard M.N., et al. Small cell lung carcinoma (SCLC): a clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002, 26:1184-1197.
18. Tai P., Assouline A., Joseph K., Stitt L., Yu E. Prophylactic cranial irradiation for patients with limited-stage small-cell lung cancer with response to chemoradiation. Clin Lung Cancer 2013, 14:40-44.
19. Janssen-Heijnen M.L., Maas H.A., Siesling S., Koning C.C., Coebergh J.W., Groen H.J. Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80. Ann Oncol 2012, 23:954-960.
20. Laurie S.A., Ding K., Whitehead M., Feld R., Murray N., Shepherd F.A., et al. The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group. Ann Oncol 2007, 18:1051-1055.
21. Hermes A., Gatzemeier U., Waschki B., Reck M. Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer-a retrospective single institution analysis. Respir Med 2010, 104:1937-1942.
22. Hong S., Kang Y.A., Cho B.C., Kim D.J. Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J 2012, 53:111-117.
23. Kalemkerian G.P., Akerley W., Bogner P., Borghaei H., Chow L.Q., Downey R.J., et al. Small cell lung cancer. J Natl Compr Canc Netw 2013, 11:78-98.
24. De Ruysscher D., Pijls-Johannesma M., Bentzen S.M., Minken A., Wanders R., Lutgens L., et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol 2006, 24:1057-1063.
25. Cheng S., Evans W.K., Stys-Norman D., Shepherd F.A. Chemotherapy for relapsed small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol 2007, 2:348-354.
26. Rossi A., Di Maio M., Chiodini P., Rudd R.M., Okamoto H., Skarlos D.V., et al. Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data. J Clin Oncol 2012, 30:1692-1698.
27. Hermes A., Waschki B., Reck M. Hyponatremia as prognostic factor in small cell lung cancer-a retrospective single institution analysis. Respir Med 2012, 106:900-904.
28. Schreiber D., Rineer J., Weedon J., Vongtama D., Wortham A., Kim A., et al. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated. Cancer 2010, 116:1350-1357.
29. Weksler B., Nason K.S., Shende M., Landreneau R.J., Pennathur A. Surgical resection should be considered for stage I and II small cell carcinoma of the lung. Ann Thorac Surg 2012, 94:889-893.
30. Pijls-Johannesma M.C., De Ruysscher D., Lambin P., Rutten I., Vansteenkiste J.F. Early versus late chest radiotherapy for limited stage small cell lung cancer. Cochrane Database Syst Rev 2005, CD004700.
31. Jett J.R., Schild S.E., Kesler K.A., Kalemkerian G.P. Treatment of small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:e400S-e419S.